Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series. Hansen S, Alduaij W, Biggs CM, Belga S, et al. Eur J Haematol 2021;106:654-661.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hansen S, Alduaij W, Biggs CM, Belga S, et al. Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series. Eur J Haematol 2021;106:654-661.
PMID: 33523540